Myriad Genetics (MYGN) Liabilities from Discontinued Operations (2019 - 2024)
Myriad Genetics (MYGN) reported Liabilities from Discontinued Operations of 4000000.0 for Q2 2024, down 67.21% quarter-over-quarter from 12200000.0 in Q2 2021.
Myriad Genetics (MYGN) Liabilities from Discontinued Operations (2019 - 2024) Analysis & Trends
Myriad Genetics (MYGN) has 3 years of Liabilities from Discontinued Operations data on file, last reported at 4000000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | Myriad Genetics | 424.93 Mn | 300.53 Mn | 137.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 4.00 Mn |
| Jun 30, 2021 | 12.20 Mn |
| Jun 30, 2021 | 12.20 Mn |
| Dec 31, 2019 | 10.50 Mn |
| Dec 31, 2019 | 10.50 Mn |